Your browser doesn't support javascript.
loading
Factors impacting COVID-19 vaccine decision making in older adults and people with underlying conditions in Victoria, Australia: A cross-sectional survey.
Biezen, Ruby; Kaufman, Jessica; Hoq, Monsurul; Manski-Nankervis, Jo-Anne; Sanci, Lena; Bell, J Simon; Leask, Julie; Seale, Holly; Munro, Jane; Suryawijaya Ong, Darren; Oliver, Jane; Jos, Carol; Tuckerman, Jane; Bagot, Kathleen; Danchin, Margie.
Afiliación
  • Biezen R; Department of General Practice, University of Melbourne, Melbourne, Australia.
  • Kaufman J; Vaccine Uptake Group, Murdoch Children's Research Institute, Melbourne, Australia.
  • Hoq M; Department of Paediatrics, University of Melbourne, Melbourne, Australia.
  • Manski-Nankervis JA; Vaccine Uptake Group, Murdoch Children's Research Institute, Melbourne, Australia.
  • Sanci L; Department of Paediatrics, University of Melbourne, Melbourne, Australia.
  • Bell JS; Department of General Practice, University of Melbourne, Melbourne, Australia.
  • Leask J; Department of General Practice, University of Melbourne, Melbourne, Australia.
  • Seale H; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia.
  • Munro J; Susan Wakil School of Nursing and Midwifery, University of Sydney, Sydney, Australia.
  • Suryawijaya Ong D; School of Population Health, University of New South Wales, Australia.
  • Oliver J; Vaccine Uptake Group, Murdoch Children's Research Institute, Melbourne, Australia.
  • Jos C; Vaccine Uptake Group, Murdoch Children's Research Institute, Melbourne, Australia.
  • Tuckerman J; Vaccine Uptake Group, Murdoch Children's Research Institute, Melbourne, Australia.
  • Bagot K; The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Australia.
  • Danchin M; Vaccine Uptake Group, Murdoch Children's Research Institute, Melbourne, Australia.
Hum Vaccin Immunother ; 18(7): 2147770, 2022 12 30.
Article en En | MEDLINE | ID: mdl-36573307
Australia's COVID-19 vaccine rollout included prioritizing older adults and those with underlying conditions. However, little was known around the factors impacting their decision to accept the vaccine. This study aimed to assess vaccine intentions, information needs, and preferences of people prioritized to receive the COVID-19 vaccine at the start of the Australian vaccine rollout. A cross-sectional online survey of people aged ≥70 years or 18-69 with chronic or underlying conditions was conducted between 12 February and 26 March 2021 in Victoria, Australia. The World Health Organization Behavioural and Social Drivers of COVID-19 vaccination framework and items informed the survey design and framing of results. Bivariate logistic regression was used to investigate the association between intention to accept a COVID-19 vaccine and demographic characteristics. In total, 1828 eligible people completed the survey. Intention to vaccinate was highest among those ≥70 years (89.6%, n = 824/920) versus those aged 18-69 years (83.8%, n = 761/908), with 91% (n = 1641/1803) of respondents agreeing that getting a COVID-19 vaccine was important to their health. Reported vaccine safety (aOR 1.4, 95% CI 1.1 to 1.8) and efficacy (aOR 1.9, 95% CI 1.5 to 2.3) were associated with intention to accept a COVID-19 vaccine. Concerns around serious illness, long-term effects, and insufficient vaccine testing were factors for not accepting a COVID-19 vaccine. Preferred communication methods included discussion with healthcare providers, with primary care providers identified as the most trusted information source. This study identified factors influencing the prioritized public's COVID-19 vaccine decision-making, including information preferences. These details can support future vaccination rollouts.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Oceania Idioma: En Revista: Hum Vaccin Immunother Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Oceania Idioma: En Revista: Hum Vaccin Immunother Año: 2022 Tipo del documento: Article